UBX

Unity Biotechnology
UBX

Overview Fund Activity
Delisted

UBX was delisted on the 8th of July, 2025.

Back to rankings

54 hedge funds and large institutions have $153M invested in Unity Biotechnology in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 27 closing their positions.

Holders
54
Holders Change
-18
Holders Change %
-25%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
23
Reduced
11
Closed
27
Calls
$4.15M
Puts
$96K
Net Calls
+$4.05M
Net Calls Change
-$1.67M

Top Buyers

1
AWA
1
Arete Wealth Advisors
Illinois
$141M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$285K
3
BCM
3
Bridgeway Capital Management
Texas
$166K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$249K
5
FFVM
5
Founders Fund V Management
California
$135K

Top Sellers

1
ACM
1
Altium Capital Management
New York
$0
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$1.91M
3
CH
3
CVI Holdings
Delaware
$0
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$685K
5
UOC
5
UBS O'Connor
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TAM
76
Tucker Asset Management
Colorado
– -$114 -4 Closed
1 2 3
4